Heterozygous familial hypercholesterolemia is a genetic disease characterized by high levels of low-density lipoprotein cholesterol. The population of people with this genetic condition faces an increasingly high cardiovascular risk, however, the degree to which this risk presents itself is dependent on additional factors. Furthermore, many that suffer from this condition go undiagnosed due to a lack of screening efficiency and thoroughness of medical practices related to this issue.
In the format of a traditional statistical analysis, we observed patient data gathered from a national multi-center registry by creating subgroups of heterozygous familial hypercholesterolemia sufferers based on the level of risk that they face in order to determine which of these additional factors contribute most to the likelihood of cardiovascular-related illness. The identification of these factors is critical in optimizing patient care pathways by improving both rates of diagnosis and treatment techniques. Additionally, the promotion of increased screenings beginning during childhood has the potential to drastically improve the treatment of heterozygous familial hypercholesterolemia, seeing as early diagnosis is crucial in successful disease management.